HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
Hanlin Ma(Qilu Hospital of Shandong University), Beihua Kong(Qilu Hospital of Shandong University), Gonghua Qi(Qilu Hospital of Shandong University), Wei Lu(Association pour l'Utilisation du Rein Artificiel), Cunzhong Yuan(Shandong University), Rongrong Li(Qilu Hospital of Shandong University), Fang Han(Qilu Hospital of Shandong University), Jia Yan(Qilu Hospital of Shandong University), Yan Shi(Qilu Hospital of Shandong University)
Cited by 48
Related Papers
Dual-Targeting Upconversion Nanoprobes across the Blood–Brain Barrier for Magnetic Resonance/Fluorescence Imaging of Intracranial Glioblastoma
|ACS Nano|2014|302
A fully biodegradable and self-electrified device for neuroregenerative medicine
|Science Advances|2020|188
"Little brothers watching you"
|Unknown|2013|180
Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer
|Nanotechnology|2011|176
TANKBind: Trigonometry-Aware Neural NetworKs for Drug-Protein Binding Structure Prediction
|bioRxiv (Cold Spring Harbor Laboratory)|2022|166